End-stage Renal Failure: Clinical Trials

3 trials for End-stage Renal Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow End-stage Renal Failure: new trials by email Literature Review of End-stage Renal Failure trials Research Report on End-stage Renal Failure

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reference Group Trial for The ONE Study
Blood drawing for immune monitoring and questionnaires - End-stage Renal Failure, Kidney Graft Rejection
Phase 4CompletedUniversity of Regensburg702012-12-012016-03-09
Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation
Tacrolimus (Kidney transplant maintenance immunosuppression), Kidney transplant maintenance immunosuppression - End-stage Renal Failure, Graft Rejection
Phase 4CompletedImperial College Healthcare NHS Trust1022008-12-012021-08-27
Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
Spironolactone - End-stage Renal Failure
Phase 4CompletedDialysis Outcomes Heart Failure Aldactone Study Group1572008-04-012012-09-19

Narrower conditions

Kidney Failure, Chronic (3)  ·  Rejection, Psychology (1)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Renal Insufficiency (3)  ·  Renal Insufficiency, Chronic (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Behavior (1)  ·  Social Behavior (1)

Interventions

Blood Specimen Collection (1)  ·  Monitoring, Immunologic (1)  ·  Spironolactone (1)  ·  Surveys and Questionnaires (1)  ·  Tacrolimus (1)

Sponsors

Dialysis Outcomes Heart Failure Aldactone Study Group (1)  ·  Imperial College Healthcare NHS Trust (1)  ·  University of Regensburg (1)

Countries

United Kingdom (2)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  United States (1)

Top investigators

Adam G McLean, MA DPhil (1)  ·  Edward K. Geissler, Ph.D. (1)

Results publications

PMID 24184249, PMID 32446407, PMID 33586138, PMID 36306921, PMID 36441083

NIH funding

2008 (1)